2026-525987-16-00招募中2 期
The headache- and migraine-inducing effects of apremilast in women with migraine without aura
适应症
干预措施
相关药物
试验速览
- 阶段
- 2 期
- 状态
- 招募中
- 入组人数
- 14
- 试验地点
- 1
- 主要终点
- Difference in the occurrence of migraine-like attacks between apremilast- and placebo-treated women with migraine without aura during the entire observational period (until 12 hours post-administration)
研究概览
简要总结
We will test the ability of a single oral administration of apremilast (30 mg) to induce migraine in women with a history of migraine without aura.
入排标准
- 年龄范围
- 18 years 至 64 years（18-64 Years）
- 性别
- Female
- 接受健康志愿者
- 否
入选标准
- •Healthy women with a diagnosis of episodic migraine without aura according to the International Classification
- •Safe contraception (including hormonal therapies, intrauterine devices and/or oral pills) during the entire period of the study
- •Age: 18-65 years
- •Weight: 50-90 kg
- •Fluency in Danish or English
排除标准
- •Any other type of headache (excluding < 3 days of tension-type headache per month), according to the International Classification
- •Positive pregnancy test at the Screening and/or before the start of each experimental day (first and second experimental administration)
- •Known allergy to any component of apremilast “Stada”
- •Member of investigational site staff or relative of investigators
- •Headache less than 24 hours before the start of the experiment
- •Drinking coffee, cola or alcohol less than 8 hours before the start of the experiment
- •Assumption of analgesic medications in the 24 hours preceding the experimental days
- •History or clinical evidence of severe psychiatric disorders (including anxiety or depression) and hepatic and/or renal impairment
- •Underweight patients (body mass index < 18.5 kg/m²)
- •Patients with rare hereditary problems of galactose intolerance, total lactase deficiency or glucose-galactose malabsorption
- •Anamnestic or clinical signs of diseases of any kind considered by the investigating physician relevant for participation in the study
- •Use of concomitant medications that have changed in dosage within 14 days prior to screening or are expected to change during the study period
研究组 & 干预措施
Lactose monohydrate
Placebo
干预措施: Lactose monohydrate (Drug)
结局指标
主要结局
Difference in the occurrence of migraine-like attacks between apremilast- and placebo-treated women with migraine without aura during the entire observational period (until 12 hours post-administration)
Difference in the occurrence of migraine-like attacks between apremilast- and placebo-treated women with migraine without aura during the entire observational period (until 12 hours post-administration)
次要结局
- Difference in headache intensities over time between apremilast- and placebo-treated women with migraine without aura during the entire observational period (until 12 hours post-administration)
- The occurrence of any headache, irrespective of migraine criteria, between apremilast- and placebo-treated women with migraine without aura during the entire observational period (until 12 hours post-administration)
- Difference in heart rate and mean arterial pressure (MAP) until 90 minutes post-administration between apremilast- and placebo-treated women with migraine without aura
- Difference in the incidence of adverse events during the entire observational period (until 12 hours post-administration) between apremilast- and placebo-treated women with migraine without aura
研究者
Clinical Pharmacology, Pharmacy and Environmental Medicine
Scientific
Syddansk Universitet (University of Southern Denmark)
研究点 (1)
Loading locations...
相似试验
尚未招募
4 期
A study on the effects of amitriptyline and propranolol on heart rate variability and lipid profile in migraineCTRI/2025/02/081025Dr. Robin Reji120
招募中
2 期
The headache- and migraine-inducing effects of pitolisant in women with migraine without auraMigraine without aura2026-525521-20-00Syddansk Universitet (University of Southern Denmark)14
尚未招募
3 期
Migraine Headaches Elimination With Patent Foramen Ovale-Directed TherapyPatent Foramen OvaleNCT07629635Columbia University32
尚未招募
3 期
A Study to Compare The Effect Of Anu Tail Nasya And Pathyadishadanga Kwath In The Management Of Ardhavabhedaka W.S.R.To MigraineCTRI/2025/09/094390Dr Sukhdev Khatotra Associate Professor Department of Kayachikitsa105
招募中
2/3 期
Homeopathic treatment of Headache in adultsCTRI/2024/12/078315D N De Homoeopathic Medical College and Hospital99